Related Experiment Video

Updated: Feb 16, 2026

Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.6K

Mediastinal germ cell tumors: new therapeutic insights

Amedeo Ferlosio1,2, Alessandra Bielli1, Augusto Orlandi1,2

  • 1Anatomic Pathology, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Roma, Italy.

Journal of Thoracic Disease
|December 23, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

1.5K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K

Related Experiment Videos

Last Updated: Feb 16, 2026

Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.6K
Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

1.5K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K

Articles linked to this work by shared authors, journal, and citation graph.

The Efficacy of Antihypertensive Drugs and miR-632 Inhibition on Parietal Remodeling in a Model of Marfan Thoracic Aortic Aneurysm.

Biomolecules·2026

Case Report: E-cadherin and Vimentin expression in advanced-stage pancreatic ductal adenocarcinoma tissue and circulating tumor cells: preliminary results from a pilot study.

Frontiers in oncology·2026

Merkel Cell Polyomavirus and DNA Damage Response (DDR): Transcriptional Analysis of DDR Pathways in the Context of Merkel Cell Carcinoma.

Cancers·2026

Potential Antifungal Activity of Retinoids Against Non-albicans Candida Species.

Microorganisms·2026

Tuberculosis-associated IRIS in a young non-HIV patient undergoing TNF-α blockade for ankylosis spondylitis: a rare case report from Italy.

Journal of clinical tuberculosis and other mycobacterial diseases·2026

AI-Driven Innovations for Quality Control and Standardization: Future Strategies in Adipose-Derived Stem Cell Manufacturing.

International journal of molecular sciences·2026

Impact of pleural anthracosis severity on the structure and function of subcarinal lymph nodes.

Journal of thoracic disease·2026

Idiopathic pulmonary fibrosis and interleukins: a bibliometric analysis [1999-2025].

Journal of thoracic disease·2026

Factors associated with Acinetobacter baumannii lower respiratory tract infection in the respiratory intensive care unit patients: a cross-sectional observational study.

Journal of thoracic disease·2026

Efficacy and safety of TQC3403 in patients with chronic obstructive pulmonary disease (COPD): a multicenter, randomized, open-label, phase 3 equivalence trial.

Journal of thoracic disease·2026

Construction and validation of an acute exacerbation risk score for fibrotic idiopathic interstitial pneumonia.

Journal of thoracic disease·2026

LTB4R inhibits apoptosis and induces radiosensitivity by promoting the PI3K/AKT pathway in esophageal squamous cell carcinoma.

Journal of thoracic disease·2026

Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Primary Cardiac Paraganglioma Management and Resection With Rare Recurrent Metastasis.

JACC. Case reports·2026

Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes.

Dalton transactions (Cambridge, England : 2003)·2026

Metal-Phenolic Networks: Emerging Nanoarchitectures for Cancer Therapy.

Angewandte Chemie (International ed. in English)·2026

Intracellular Delivery of Antibody-Based Therapeutics for Targeted Oncogenic c-Myc Degradation in Mammalian Cells and Mice.

Angewandte Chemie (International ed. in English)·2026

Tripping the switch: p38 inhibition unlocks venetoclax and inotuzumab ozogamicin synergy.

Haematologica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us